Disciplined Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-96
Closed -$7.4K 669
2023
Q2
$7.4K Sell
96
-2
-2% -$160 ﹤0.01% 357
2023
Q1
$8.13K Sell
98
-9
-8% -$745 ﹤0.01% 367
2022
Q4
$9.19K Buy
107
+4
+4% +$317 ﹤0.01% 328
2022
Q3
$6K Buy
103
+15
+17% +$946 ﹤0.01% 404
2022
Q2
$5K Buy
88
+7
+9% +$433 ﹤0.01% 441
2022
Q1
$5K Buy
81
+34
+72% +$2.17K ﹤0.01% 456
2021
Q4
$3K Hold
47
﹤0.01% 416
2021
Q3
$3K Hold
47
﹤0.01% 370
2021
Q2
$3K Hold
47
﹤0.01% 361
2021
Q1
$3K Buy
47
+14
+42% +$903 ﹤0.01% 314
2020
Q4
$2K Sell
33
-290
-90% -$17.5K ﹤0.01% 285
2020
Q3
$20K Buy
323
+100
+45% +$6.93K 0.01% 213
2020
Q2
$17K Hold
223
0.01% 241
2020
Q1
$17K Hold
223
0.02% 229
2019
Q4
$14K Buy
+223
New +$14.5K 0.01% 271

Other funds holding GILD

Disciplined Investments's GILD Position: Q3 2023 in Review

Disciplined Investments sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 96 shares — an estimated $7.4K sold.

Disciplined Investments first reported a position in GILD in Q4 2019 and held it in 15 quarters. The position peaked at $20K in Q3 2020. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

  • Disciplined Investments reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 96 Gilead Sciences shares in Q3 2023, an estimated $7.4K.
  • Disciplined Investments first reported a position in Gilead Sciences in Q4 2019 and held it in 15 quarters.
  • Disciplined Investments's Gilead Sciences position peaked at $20K in Q3 2020.
  • 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.